Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arie Weinstock

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Epilepsia|April 20, 2007
Pharmacokinetics of levetiracetam in infants and young children with epilepsyTracy A Glauser, Wendy G Mitchell, Arie Weinstock, et al.
Epilepsia Open|August 1, 2024
Long-term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3-year results from the cannabidiol expanded access programArie Weinstock, E Martina Bebin, Daniel Checketts, et al.
Journal of Child Neurology|March 28, 2013
Prospective Open-Label, Single-Arm, Multicenter, Safety, Tolerability, and Pharmacokinetic Studies of Intravenous Levetiracetam in Children With EpilepsyArie Weinstock, Matilde Ruiz, Danielle Gerard, et al.
BMC Neurology|June 19, 2014
MRI segmentation analysis in temporal lobe and idiopathic generalized epilepsyHila Goldberg, Arie Weinstock, Niels Bergsland, et al.
Epilepsy Research|April 26, 2019
Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program resultsLinda C Laux, E Martina Bebin, Daniel Checketts, et al.
Epilepsia|July 21, 2021
Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: Results of a long-term open-label extension trialAnup D Patel, Maria Mazurkiewicz-Bełdzińska, Richard F Chin, et al.
Epilepsia|May 27, 2023
Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the Expanded Access ProgramRobert J Flamini, Anne M Comi, E Martina Bebin, et al.
JAMA Neurology|October 31, 2022
Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical PracticeDianalee McKnight, Ana Morales, Kathryn E Hatchell, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Epilepsia|April 20, 2007
Pharmacokinetics of levetiracetam in infants and young children with epilepsyTracy A Glauser, Wendy G Mitchell, Arie Weinstock, et al.
Epilepsia Open|August 1, 2024
Long-term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3-year results from the cannabidiol expanded access programArie Weinstock, E Martina Bebin, Daniel Checketts, et al.
Journal of Child Neurology|March 28, 2013
Prospective Open-Label, Single-Arm, Multicenter, Safety, Tolerability, and Pharmacokinetic Studies of Intravenous Levetiracetam in Children With EpilepsyArie Weinstock, Matilde Ruiz, Danielle Gerard, et al.
BMC Neurology|June 19, 2014
MRI segmentation analysis in temporal lobe and idiopathic generalized epilepsyHila Goldberg, Arie Weinstock, Niels Bergsland, et al.
Epilepsy Research|April 26, 2019
Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program resultsLinda C Laux, E Martina Bebin, Daniel Checketts, et al.
Epilepsia|July 21, 2021
Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: Results of a long-term open-label extension trialAnup D Patel, Maria Mazurkiewicz-Bełdzińska, Richard F Chin, et al.
Epilepsia|May 27, 2023
Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the Expanded Access ProgramRobert J Flamini, Anne M Comi, E Martina Bebin, et al.
JAMA Neurology|October 31, 2022
Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical PracticeDianalee McKnight, Ana Morales, Kathryn E Hatchell, et al.
Pageof 2